SPOREGEN LIMITED
Company Details
Status: Private
Employees: 1-10
Location:
London, England
Type:
sample
sample
Technology:
sample
sample
About: SPOREGEN LIMITED is a biotechnology company based at The London BioScience Innovation Centre (LBIC) in London.
SPOREGEN is focused on four areas.
1. Clostridium difficile: we have developed a unique prophylactic and therapeutic approach for C. difficile infection.
2. Probiotics: we identify and develop Bacillus, heat stable, spore probiotic formulations. This includes progression to GRAS status and a number of these have now been licenced including HU58 and HU36.
3. Prophylactic approaches to COVID-19 including SPOR-COV, a unique mucosal immune modulator, and SPORCOVAX, a mucosal vaccine.
4. Contracts: focusing primarily on in vivo evaluations of C. difficile interventions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
SPOREGEN LIMITED | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.